Interpretation of Chinese biotin export market trends

The real turning point of Chinese biotin production came in 2001 and 2002. Chinese researchers first invented the "d-biological factors asymmetric synthesis of a new process" in the international market, since then, broken the long time leading position of big Western companies in biotin synthesis process. China take the new technology to produce biotin, the production cost is less than 1/3 of the Western companies’ biotin production costs. This new biotin production process firmly established the "pricing power" of Chinese biotin products in the international pharmaceutical market (like Chinese researchers invented vitamin C “2 -step synthesis of new process” in the 1970s). The development of Chinese biotin synthesis new processes have become one of the world's largest biotin manufacturer, It is reported that China's production capacity is about 50% of the total capacity of the world, export volume ranking first in the world, the 2007 export volume accounting for 70% of the actual sales of the biotin international market.

China is a biotin producing country, the products produced by biotin manufacturers are very popular in the international market. Since the beginning of 2008, the international market prices of biotin enter into the rising channel. The experts believe that the biotin export volume in recent years will continue to rise, have good export prospects.

Biotin, also known as "Vitamin H", is belonging to one of the B vitamins. In the early 1990s, Western pharmacologists found biotin has a lot of interesting new uses, including prevent the fetus because of the abnormal development of neural tube to cause birth defects, promote the body lipolysis - weight loss, from then on, biotin attracted the attention of the medical field. Recent research demonstrates that biotin is also effective in treating the type 2 diabetes which with high incidence in the world, this discovery makes the hard sell biotin become the shopping-rush goods in the world's pharmaceutical market.

Before 1990s, the international biotin market has been monopolized by a few large companies in the West. Although China had already begun to produce biotin as early as in the late 1960s, but due to affected by backward technology and production cost and other factors, the production is always not high, only meet part of the demand of the Chinese market, need to import a large part each year. This situation in the early 1990s began to change. With the international biotin market’s price increasing, Chinese pharmaceutical companies began to actively engaging in the production of bulk drugs biotin. With the biotin manufacturers’ team rapidly expanding, China is not only end of long-term dependence on importing, but also began to flock a large number of biotin to the international market. Until 1998, Chinese biotin exported was accounted for half of the international biotin market. However, China's exported biotin is basically the lower added value feed grade biotin, and higher selling price of pharmaceutical grade or cosmetic raw materials levels biotin market is still monopolized by big Western companies. It is understood that, in the past few years, the international biotin market constitute: feed grade account for about 80%, pharmaceutical grade, cosmetic raw material and health food grade biotin accounted for the remaining 20% share.

Source:http://www.cosprm.com